Novitron International reverts to Clinical Data:
This article was originally published in Clinica
Executive Summary
Novitron International, the Boston, Massachusetts company that provides instruments, assays and services for physician office laboratories (POLs) and other smaller labs, has changed its name to Clinical Data as of October 7. Over the past year the company has made a series of acquisitions of lab supplies and POL management service firms, and says the new name better expresses its strategic focus. In fact, it changed its name from Clinical Data to Novitron in 1994, to reflect its intended focus on analytical instrumentation.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.